Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00355758 · ClinicalTrials.gov registry record
UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling
A clinical trial, sponsored by University of California, Irvine.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00355758: Clinical Trial study, sponsored by University of California, Irvine.
NCT00355758 is a clinical trial that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00355758 was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
: Researchers would like to see if a new test called SELDI (Surface Enhanced Laser Desorption Ionization) analysis can predict biopsy results better than PSA tests.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-06 |
Why NCT00355758 stopped before completion
NCT00355758 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00355758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00355758 about?
NCT00355758 is a clinical study titled "UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling". : Researchers would like to see if a new test called SELDI (Surface Enhanced Laser Desorption Ionization) analysis can predict biopsy results better than PSA tests.
What is the current status of trial NCT00355758?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2005-04. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00355758?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia